United States · Series A startup

Who invested in Vesalius Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$75Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $75MMar 2022
Investors
1
See who backed them

The rounds

  1. Mar 2022
    Series A$75M

    Source recorded

Founders and team

From Vesalius Therapeutics's own website: 1 on the team.

  • John HulburtVP, Head of Finance

Everyone who backed them

Flagship PioneeringVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Vesalius Therapeutics

Who invested in Vesalius Therapeutics?

Vesalius Therapeutics's investors include Flagship Pioneering.

How much has Vesalius Therapeutics raised?

Vesalius Therapeutics has raised $75M across 1 round since 2022.

When did Vesalius Therapeutics last raise?

Vesalius Therapeutics's most recent round was a Series A of $75M in Mar 2022.

What was Vesalius Therapeutics's biggest round?

Its most recent round, $75M in Mar 2022, is also its largest on record.

Who backed Vesalius Therapeutics first?

Vesalius Therapeutics's first round on record, in Mar 2022, was backed by Flagship Pioneering.

What stage is Vesalius Therapeutics at?

Vesalius Therapeutics's latest named round is a Series A, in Mar 2022.

Where is Vesalius Therapeutics based?

Vesalius Therapeutics is based in the United States.

Companies like Vesalius Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.